294 related articles for article (PubMed ID: 10671882)
1. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
2. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience.
de la Taille A; Hayek O; Benson MC; Bagiella E; Olsson CA; Fatal M; Katz AE
Urology; 2000 Jan; 55(1):79-84. PubMed ID: 10654899
[TBL] [Abstract][Full Text] [Related]
3. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
4. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
5. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
6. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.
Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H
Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004
[TBL] [Abstract][Full Text] [Related]
7. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
8. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.
Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS
Perm J; 2019; 23():. PubMed ID: 31050644
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
[TBL] [Abstract][Full Text] [Related]
10. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up.
Bahn DK; Lee F; Silverman P; Bahn E; Badalament R; Kumar A; Greski J; Rewcastle JC
Clin Prostate Cancer; 2003 Sep; 2(2):111-4. PubMed ID: 15040872
[TBL] [Abstract][Full Text] [Related]
11. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.
Shinohara K; Rhee B; Presti JC; Carroll PR
J Urol; 1997 Dec; 158(6):2206-9; discussion 2209-10. PubMed ID: 9366345
[TBL] [Abstract][Full Text] [Related]
12. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
[TBL] [Abstract][Full Text] [Related]
13. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS
J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170
[TBL] [Abstract][Full Text] [Related]
14. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
15. Primary Whole-gland Cryoablation for Prostate Cancer: Biochemical Failure and Clinical Recurrence at 5.6 Years of Follow-up.
Oishi M; Gill IS; Ashrafi AN; Lin-Brande M; Nassiri N; Shin T; Bove A; Cacciamani GE; Ukimura O; Bahn DK; Abreu ALC
Eur Urol; 2019 Feb; 75(2):208-214. PubMed ID: 30274702
[TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and complications of salvage cryotherapy of the prostate.
Pisters LL; von Eschenbach AC; Scott SM; Swanson DA; Dinney CP; Pettaway CA; Babaian RJ
J Urol; 1997 Mar; 157(3):921-5. PubMed ID: 9072600
[TBL] [Abstract][Full Text] [Related]
18. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre.
Wenske S; Quarrier S; Katz AE
Eur Urol; 2013 Jul; 64(1):1-7. PubMed ID: 22840351
[TBL] [Abstract][Full Text] [Related]
19. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
20. Salvage cryoablation for local recurrence of prostatic cancer after curative therapy.
Barat M; Colleter L; Mongiat-Artus P; Jolibois Z; Quero L; Hennequin C; Desgrandchamps F; de Kerviler E
Diagn Interv Imaging; 2019 Nov; 100(11):679-687. PubMed ID: 31331832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
